Petersen Elisabeth Krogsgaard, Hanberg Pelle, Knudsen Martin, Tøstesen Sara Kousgaard, Jørgensen Andrea René, Öbrink-Hansen Kristina, Søballe Kjeld, Stilling Maiken, Bue Mats
Department of Clinical Medicine, Aarhus University, 8200 Aarhus, Denmark.
Aarhus Denmark Microdialysis Research (ADMIRE), Orthopaedic Research Laboratory, Aarhus University Hospital, 8200 Aarhus, Denmark.
Antibiotics (Basel). 2022 Jul 7;11(7):910. doi: 10.3390/antibiotics11070910.
Background: Piperacillin is a central drug in the treatment of Pseudomonas aeruginosa spondylodiscitis. Intermittent short-term infusion (STI) remains standard treatment in most centres, although the application of continuous infusion (CI) has shown promising results in other clinical settings. We aimed to evaluate time above the minimal inhibitory concentration (fT > MIC) of the free fraction of piperacillin in steady state conditions in porcine cervical spine tissue following CI and STI using microdialysis with MIC targets of 4, 8, and 16 μg/mL. Methods: 16 female pigs were randomized to receive piperacillin/tazobactam as STI (4/0.5 g every 6 h) or CI (4/0.5 g as a bolus followed by 12/1.5 g) for 18 h. Microdialysis catheters were placed for sampling of piperacillin concentrations from the intervertebral disc, vertebral cancellous bone, paravertebral muscle, and adjacent subcutaneous tissue during the third dosing interval (12−18 h). Blood samples were collected as reference. Results: CI resulted in fT > MIC > 82% across all compartments and targets, except for intervertebral disc (37%) and vertebral cancellous bone (28%) at MIC = 16 μg/mL. In Group STI, >72% fT > MIC was reached for MIC = 4 μg/mL in all investigated compartments, while for MIC = 16 μg/mL only subcutaneous tissue exhibited fT > MIC > 50%. Conclusion: CI of piperacillin resulted in higher fT > MIC compared to STI infusion across the investigated tissues and targets. CI should therefore be considered in spondylodiscitis cases requiring piperacillin treatment.
哌拉西林是治疗铜绿假单胞菌性脊椎间盘炎的核心药物。在大多数中心,间歇性短期输注(STI)仍是标准治疗方法,尽管持续输注(CI)在其他临床环境中已显示出有前景的结果。我们旨在使用微透析评估在猪颈椎组织稳态条件下,以4、8和16μg/mL为MIC靶点,CI和STI后哌拉西林游离部分高于最低抑菌浓度的时间(fT>MIC)。方法:16只雌性猪被随机分配接受哌拉西林/他唑巴坦作为STI(每6小时4/0.5g)或CI(4/0.5g静脉推注,随后12/1.5g),持续18小时。在第三个给药间隔(12 - 18小时)期间,放置微透析导管以从椎间盘、椎体松质骨、椎旁肌肉和相邻皮下组织采集哌拉西林浓度样本。采集血样作为对照。结果:CI导致所有腔室和靶点的fT>MIC>82%,但在MIC = 16μg/mL时,椎间盘(37%)和椎体松质骨(28%)除外。在STI组中,对于MIC = 4μg/mL,所有研究腔室的fT>MIC均>72%,而对于MIC = 16μg/mL,只有皮下组织的fT>MIC>50%。结论:与STI输注相比,哌拉西林CI导致在所研究的组织和靶点中fT>MIC更高。因此,在需要哌拉西林治疗的脊椎间盘炎病例中应考虑CI。